Avidity Biosciences Inc.

Avidity Biosciences Inc. is a biotechnology company focused on the development of innovative therapies for unmet medical needs. The primary aim of Avidity is to harness its proprietary Antibody Oligonucleotide Conjugates (AOCs) platform to create transformative healthcare solutions. This platform combines antibodies and oligonucleotides to precisely target and deliver therapeutic payloads to specific diseased cells, potentially advancing treatments for a range of genetic disorders. The company's research primarily impacts sectors such as rare disease treatment and genetic medicine, where precision and efficacy are critical. By leveraging its unique technology, Avidity Biosciences plays a significant role in the biotechnology landscape, fostering advancements that seek to alter the genetic disease treatment paradigm and improve patient outcomes globally.